Export 17 results:
Author Title Type [ Year(Desc)]
Filters: Author is Michael, Nelson L  [Clear All Filters]
M. L. Robb, Rerks-Ngarm, S., Nitayaphan, S., Pitisuttithum, P., Kaewkungwal, J., Kunasol, P., Khamboonruang, C., Thongcharoen, P., Morgan, P., Benenson, M., Paris, R. M., Chiu, J., Adams, E., Francis, D., Gurunathan, S., Tartaglia, J., Gilbert, P., Stablein, D., Michael, N. L., and Kim, J. H., Risk behaviour and time as covariates for efficacy of the HIV vaccine regimen ALVAC-HIV (vCP1521) and AIDSVAX B/E: a post-hoc analysis of the Thai phase 3 efficacy trial RV 144., Lancet Infect Dis, vol. 12, no. 7, pp. 531-7, 2012.
M. S. de Souza, Ratto-Kim, S., Chuenarom, W., Schuetz, A., Chantakulkij, S., Nuntapinit, B., Valencia-Micolta, A., Thelian, D., Nitayaphan, S., Pitisuttithum, P., Paris, R. M., Kaewkungwal, J., Michael, N. L., Rerks-Ngarm, S., Mathieson, B., Marovich, M., Currier, J. R., and Kim, J. H., The Thai phase III trial (RV144) vaccine regimen induces T cell responses that preferentially target epitopes within the V2 region of HIV-1 envelope., J Immunol, vol. 188, no. 10, pp. 5166-76, 2012.
D. H. Barouch, Liu, J., Li, H., Maxfield, L. F., Abbink, P., Lynch, D. M., M Iampietro, J., SanMiguel, A., Seaman, M. S., Ferrari, G., Forthal, D. N., Ourmanov, I., Hirsch, V. M., Carville, A., Mansfield, K. G., Stablein, D., Pau, M. G., Schuitemaker, H., Sadoff, J. C., Billings, E. A., Rao, M., Robb, M. L., Kim, J. H., Marovich, M. A., Goudsmit, J., and Michael, N. L., Vaccine protection against acquisition of neutralization-resistant SIV challenges in rhesus monkeys., Nature, vol. 482, no. 7383, pp. 89-93, 2012.
A. Letizia, Eller, M. A., Polyak, C., Eller, L. Anne, Creegan, M., Dawson, P., Bryant, C., D, K., Crowell, T. A., Lombardi, K., Rono, E., Robb, M. L., Michael, N. L., Maswai, J., and Ake, J. A., Biomarkers of Inflammation Correlate With Clinical Scoring Indices in Human Immunodeficiency Virus-Infected Kenyans., J Infect Dis, vol. 219, no. 2, pp. 284-294, 2019.
T. A. Crowell, Colby, D. J., Pinyakorn, S., Sacdalan, C., Pagliuzza, A., Intasan, J., Benjapornpong, K., Tangnaree, K., Chomchey, N., Kroon, E., de Souza, M. S., Tovanabutra, S., Rolland, M., Eller, M. A., Paquin-Proulx, D., Bolton, D. L., Tokarev, A., Thomas, R., Takata, H., Trautmann, L., Krebs, S. J., Modjarrad, K., McDermott, A. B., Bailer, R. T., Doria-Rose, N., Patel, B., Gorelick, R. J., Fullmer, B. A., Schuetz, A., Grandin, P. V., O'Connell, R. J., Ledgerwood, J. E., Graham, B. S., Tressler, R., Mascola, J. R., Chomont, N., Michael, N. L., Robb, M. L., Phanuphak, N., and Ananworanich, J., Safety and efficacy of VRC01 broadly neutralising antibodies in adults with acutely treated HIV (RV397): a phase 2, randomised, double-blind, placebo-controlled trial., Lancet HIV, vol. 6, no. 5, pp. e297-e306, 2019.
K. Modjarrad, Roberts, C. C., Mills, K. T., Castellano, A. R., Paolino, K., Muthumani, K., Reuschel, E. L., Robb, M. L., Racine, T., Oh, M. - D., Lamarre, C., Zaidi, F. I., Boyer, J., Kudchodkar, S. B., Jeong, M., Darden, J. M., Park, Y. K., Scott, P. T., Remigio, C., Parikh, A. P., Wise, M. C., Patel, A., Duperret, E. K., Kim, K. Y., Choi, H., White, S., Bagarazzi, M., May, J. M., Kane, D., Lee, H., Kobinger, G., Michael, N. L., Weiner, D. B., Thomas, S. J., and Maslow, J. N., Safety and immunogenicity of an anti-Middle East respiratory syndrome coronavirus DNA vaccine: a phase 1, open-label, single-arm, dose-escalation trial., Lancet Infect Dis, vol. 19, no. 9, pp. 1013-1022, 2019.
P. K. Ehrenberg, Shangguan, S., Issac, B., Alter, G., Geretz, A., Izumi, T., Bryant, C., Eller, M. A., Wegmann, F., Apps, R., Creegan, M., Bolton, D. L., Sekaly, R. P., Robb, M. L., Gramzinski, R. A., Pau, M. G., Schuitemaker, H., Barouch, D. H., Michael, N. L., and Thomas, R., A vaccine-induced gene expression signature correlates with protection against SIV and HIV in multiple trials., Sci Transl Med, vol. 11, no. 507, 2019.